
Loading, please wait...

Loading, please wait...

Star Health financial growth reached a new peak as the insurer reported a net profit of Rs 111 crore. This multi-fold jump occurred during the fourth quarter ending March 2026. However, the company recorded a mere Rs 50 lakh profit in the same quarter last year. Consequently, the firm showed a significant recovery in its financial performance. Total income increased to Rs 4,545 crore from Rs 3,989 crore during the reporting period.
Gross written premiums rose to Rs 5,968 crore against Rs 5,138 crore in the year-ago period. Furthermore, net premiums increased to Rs 5,599 crore from Rs 4,820 crore. Additionally, the company focused on its retail health portfolio to drive sustainable margins. This strategy helped improve the combined ratio to 95.7% during the quarter. Therefore, medical professionals should note the insurer's improving stability for claim settlements.
Underwriting losses significantly dropped to Rs 154 crore from Rs 275 crore in the prior year. Moreover, the insurer settled approximately 30 lakh claims during the full financial year 2026. Total payouts for these claims exceeded Rs 11,900 crore. Specifically, the retail loss ratio saw a decline, reflecting better risk selection. Since doctors rely on timely insurance payments, these metrics indicate a positive operational trend.
Q1: What was Star Health's net profit in the final quarter of FY26?
The company reported a net profit of Rs 111 crore, which is a massive increase from the Rs 50 lakh profit reported in the same quarter of the previous year.
Q2: How did the underwriting loss change compared to the previous year?
The underwriting loss narrowed to Rs 154 crore from Rs 275 crore, indicating more disciplined risk management and better operational efficiency.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Star Health reported a net profit jump to Rs 111 crore in Q4 FY26, driven by premium growth and reduced underwriting losses in the health sector....
5 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today